tetano
Editor, Senior Moderator
Cureus
. 2023 Apr 19;15(4):e37814.
doi: 10.7759/cureus.37814. eCollection 2023 Apr. Bulbar Onset Amyotrophic Lateral Sclerosis in a COVID-19 Patient: A Case Report
Mohammad Abu-Abaa[SUP] 1 [/SUP], Aliaa Mousa[SUP] 1 [/SUP], Sindhu Chadalawada[SUP] 1 [/SUP], Ali Abdulsahib[SUP] 1 [/SUP]
Affiliations
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder with a largely unknown etiology. In this case, we are presenting an 84-year-old male patient who was admitted for acute hypoxemic respiratory failure secondary to coronavirus disease 2019 (COVID-19) infection. He was neurologically intact. His infection improved and oxygen requirement was gradually weaned off allowing for discharge. However, he was admitted again a month later with progressive dysphagia and aspiration that were confirmed on videofluoroscopic study. He was also found to have mild dysarthria, bulbar muscle weakness, bilateral lower motor neuron facial nerve palsy, diffuse hyporeflexia on four extremities with intact sensory function. Diagnosis of ALS was suspected after extensive workup was pursued and ruled out nutritional, structural, autoimmune, infectious and inflammatory disorders. This case is only the third reported case in medical literature to suggest COVID-19 infection as a triggering/accelerating factor of ALS progression.
Keywords: amyotrophic lateral sclerosis; bulbar palsy; covid-19; dysarthria; dysphagia.
. 2023 Apr 19;15(4):e37814.
doi: 10.7759/cureus.37814. eCollection 2023 Apr. Bulbar Onset Amyotrophic Lateral Sclerosis in a COVID-19 Patient: A Case Report
Mohammad Abu-Abaa[SUP] 1 [/SUP], Aliaa Mousa[SUP] 1 [/SUP], Sindhu Chadalawada[SUP] 1 [/SUP], Ali Abdulsahib[SUP] 1 [/SUP]
Affiliations
- PMID: 37214058
- PMCID: PMC10197023
- DOI: 10.7759/cureus.37814
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder with a largely unknown etiology. In this case, we are presenting an 84-year-old male patient who was admitted for acute hypoxemic respiratory failure secondary to coronavirus disease 2019 (COVID-19) infection. He was neurologically intact. His infection improved and oxygen requirement was gradually weaned off allowing for discharge. However, he was admitted again a month later with progressive dysphagia and aspiration that were confirmed on videofluoroscopic study. He was also found to have mild dysarthria, bulbar muscle weakness, bilateral lower motor neuron facial nerve palsy, diffuse hyporeflexia on four extremities with intact sensory function. Diagnosis of ALS was suspected after extensive workup was pursued and ruled out nutritional, structural, autoimmune, infectious and inflammatory disorders. This case is only the third reported case in medical literature to suggest COVID-19 infection as a triggering/accelerating factor of ALS progression.
Keywords: amyotrophic lateral sclerosis; bulbar palsy; covid-19; dysarthria; dysphagia.